Infection Control News

Updated COVID-19 shots, including bivalent boosters, dominated vaccine news in 2022, but good news also came for vaccines against malaria, Ebola and cancer.

People with MS who are being treated with rituximab are strongly encouraged to receive mRNA SARS-CoV-2 vaccines and booster doses more than 6 months after their last rituximab infusion, researchers reported in JAMA Network Open.

Mpox spread around the globe in 2022, popping up in 110 countries — including 103 that had not historically reported the disease, according to CDC tracking.

An asymptomatic SARS-CoV-2 patient admission testing program can provide clinically relevant data, even during periods of lower transmission in which testing can be limited to patients who are not fully vaccinated, a recent study showed.

Over the past year, Healio has covered new discoveries about the COVID-19 vaccine, including evidence of its efficacy, the impact of vaccination during pregnancy, uptake disparities and more.

During the 2021-2022 influenza season, vaccination significantly reduced outpatient visits, consistent with prior seasons during which A(H3N2) viruses were predominant, especially among younger patients, recent study data showed.

In an exclusive interview conducted during his final days in office, Anthony S. Fauci, MD, reflected on his time with the National Institute of Allergy and Infectious Diseases and what is next for him and the field of infectious disease.

As the COVID-19 pandemic enters its 4th year, its effect on children continues to be widely studied. We compiled a list of pediatric COVID-19 stories reported over the course of the past year.

Malaria cases and deaths stabilized in 2021 after increasing in 2020 as the mosquito-borne disease took a back seat to COVID-19 and an exploding pandemic.

Protection against the omicron variant from the Pfizer-BioNTech COVID-19 vaccine waned after 3 months in children aged 5 to 11 years but was restored by a booster shot, according to study findings published in JAMA Network Open.